Brief: Adaptive Biotechnologies Reports Fourth Quarter Results

Adaptive Biotechnologies

14/02/2023 21:46

Feb 14 (Reuters) - Adaptive Biotechnologies Corp
 ADPT.O :
    * ADAPTIVE BIOTECHNOLOGIES REPORTS FOURTH QUARTER AND FULL
YEAR
2022 FINANCIAL RESULTS
    * EXPECTS FULL YEAR 2023 REVENUE TO BE IN RANGE OF $205
MILLION TO
$215 MILLION
    * EXPECT 2023 OPERATING EXPENSES, INCLUDING COST OF REVENUE,
TO BE
BELOW FULL YEAR 2022 OPERATING EXPENSES OF $385.5 MILLION
    * Q4 EARNINGS PER SHARE VIEW $-0.35, REVENUE VIEW $54.7
MILLION --
REFINITIV IBES DATA

Source text for Eikon:  ID:nGNXBdknF 
Further company coverage:  ADPT.O 
 ((Reuters.Briefs@thomsonreuters.com;))